GSK hands rare disease gene therapies over to Orchard
admin 12th April 2018 Uncategorised 0Orchard Therapeutics has snapped up GlaxoSmithKline’s portfolio of approved and investigational rare disease gene therapies. More: GSK hands rare disease gene therapies over to Orchard Source: News
read more